Gianluca Trifirò Ilaria Marcianò Paola M Cutroneo Edoardo Spina Eliana Mirabelli Costantino J Trombetta Francesca Morgante
10.3389/fphar.2018.00608
Front Pharmacol
2018 Jun 8;9:608.
parkinson’s disease anti-vascular endothelial growth factors intravitreal neurodegeneration ranibizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/29937731/
PMC6003275
29937731
Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson's Disease: A Case Report
2018